Skye Bioscience (SKYE) Competitors $1.43 +0.03 (+2.14%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$1.39 -0.04 (-3.08%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SKYE vs. TVGN, ACIU, CRGX, VYGR, AMRN, LFVN, BTMD, CTNM, RZLT, and NGNEShould you be buying Skye Bioscience stock or one of its competitors? The main competitors of Skye Bioscience include Tevogen Bio (TVGN), AC Immune (ACIU), CARGO Therapeutics (CRGX), Voyager Therapeutics (VYGR), Amarin (AMRN), LifeVantage (LFVN), biote (BTMD), Contineum Therapeutics (CTNM), Rezolute (RZLT), and Neurogene (NGNE). These companies are all part of the "pharmaceutical products" industry. Skye Bioscience vs. Tevogen Bio AC Immune CARGO Therapeutics Voyager Therapeutics Amarin LifeVantage biote Contineum Therapeutics Rezolute Neurogene Tevogen Bio (NASDAQ:TVGN) and Skye Bioscience (NASDAQ:SKYE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability. Do analysts recommend TVGN or SKYE? Tevogen Bio currently has a consensus price target of $7.10, suggesting a potential upside of 563.55%. Skye Bioscience has a consensus price target of $18.00, suggesting a potential upside of 1,158.74%. Given Skye Bioscience's higher possible upside, analysts clearly believe Skye Bioscience is more favorable than Tevogen Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tevogen Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Skye Bioscience 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor TVGN or SKYE? In the previous week, Tevogen Bio had 1 more articles in the media than Skye Bioscience. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for Skye Bioscience. Tevogen Bio's average media sentiment score of 0.19 beat Skye Bioscience's score of 0.00 indicating that Tevogen Bio is being referred to more favorably in the media. Company Overall Sentiment Tevogen Bio Neutral Skye Bioscience Neutral Does the MarketBeat Community believe in TVGN or SKYE? Skye Bioscience received 11 more outperform votes than Tevogen Bio when rated by MarketBeat users. CompanyUnderperformOutperformTevogen BioOutperform Votes3100.00% Underperform VotesNo VotesSkye BioscienceOutperform Votes14100.00% Underperform VotesNo Votes Is TVGN or SKYE more profitable? Skye Bioscience's return on equity of -45.78% beat Tevogen Bio's return on equity.Company Net Margins Return on Equity Return on Assets Tevogen BioN/A -396.07% 749.97% Skye Bioscience N/A -45.78%-37.44% Do institutionals and insiders believe in TVGN or SKYE? 21.1% of Skye Bioscience shares are owned by institutional investors. 56.6% of Tevogen Bio shares are owned by company insiders. Comparatively, 3.0% of Skye Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has stronger earnings and valuation, TVGN or SKYE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTevogen BioN/AN/A-$70KN/AN/ASkye BioscienceN/AN/A-$37.65M-$0.72-1.99 Which has more volatility & risk, TVGN or SKYE? Tevogen Bio has a beta of -1.07, indicating that its share price is 207% less volatile than the S&P 500. Comparatively, Skye Bioscience has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. SummarySkye Bioscience beats Tevogen Bio on 6 of the 11 factors compared between the two stocks. Remove Ads Get Skye Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for SKYE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SKYE vs. The Competition Export to ExcelMetricSkye BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.29M$6.77B$5.58B$7.92BDividend YieldN/A2.80%5.35%4.04%P/E Ratio-1.997.1123.0918.81Price / SalesN/A207.46368.8188.91Price / CashN/A65.6738.1634.64Price / Book-8.416.146.694.18Net Income-$37.65M$142.11M$3.20B$247.10M7 Day Performance-33.10%-6.00%-3.93%-2.72%1 Month Performance-43.23%-6.96%1.69%-3.90%1 Year Performance-89.36%-12.14%8.39%-0.11% Skye Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SKYESkye Bioscience1.2409 of 5 stars$1.43+2.1%$18.00+1,158.7%-89.9%$44.29MN/A-1.9911TVGNTevogen Bio3.1839 of 5 stars$1.08-10.0%$7.10+557.4%-63.7%$189.06MN/A0.003ACIUAC Immune2.4676 of 5 stars$1.87-5.6%$12.00+541.7%-30.4%$187.77M$27.31M-4.07140Short Interest ↑News CoverageGap DownCRGXCARGO Therapeutics3.1512 of 5 stars$4.07-2.6%$15.00+268.6%-79.8%$187.43MN/A-0.96116VYGRVoyager Therapeutics4.5382 of 5 stars$3.38-7.4%$13.97+313.2%-65.6%$186.60M$80.00M4.76100AMRNAmarin0.9619 of 5 stars$0.45+1.8%N/A-56.4%$184.02M$228.61M-4.98360Analyst ForecastLFVNLifeVantage3.2381 of 5 stars$14.58+1.1%$30.50+109.2%+148.1%$182.99M$212.15M26.04260BTMDbiote2.8208 of 5 stars$3.33-1.8%$8.00+140.2%-40.0%$182.18M$197.19M12.81194Insider TradeGap DownHigh Trading VolumeCTNMContineum Therapeutics1.5645 of 5 stars$6.98-1.3%$24.80+255.3%N/A$180.59M$50M-1.4231Positive NewsRZLTRezolute2.8694 of 5 stars$2.90-1.0%$24.38+740.5%+31.9%$175.55MN/A-2.3840News CoveragePositive NewsHigh Trading VolumeNGNENeurogene2.5192 of 5 stars$11.71-19.4%$59.80+410.7%-76.5%$174.83M$925,000.00-2.7490High Trading Volume Remove Ads Related Companies and Tools Related Companies TVGN Alternatives ACIU Alternatives CRGX Alternatives VYGR Alternatives AMRN Alternatives LFVN Alternatives BTMD Alternatives CTNM Alternatives RZLT Alternatives NGNE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SKYE) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
